Invesco Mort Financials
Invesco Mort (IVR) reported $295.3M in revenue for fiscal year 2025, up 3.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
IVR’s earnings engine is a leveraged balance sheet, where small asset-level gains translate into much larger equity results.
Across the recent recovery, net income moved from-$15.9M to$101.3M even though the top line barely changed. Because operating cash flow stayed positive through the same stretch, the turnaround looks more like improved balance-sheet economics than a volume-driven recovery, with cash supporting the accounting profit.
With ROA at
Recent asset growth was externally funded:
Financial Health Signals
Invesco Mort does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.
Invesco Mort passes 4 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), neither operating efficiency signal passes.
For every $1 of reported earnings, Invesco Mort generates $1.55 in operating cash flow ($157.1M OCF vs $101.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Key Financial Metrics
Earnings & Revenue
Invesco Mort generated $295.3M in revenue in fiscal year 2025. This represents an increase of 3.1% from the prior year.
Invesco Mort reported $101.3M in net income in fiscal year 2025. This represents an increase of 69.1% from the prior year.
Invesco Mort earned $1.32 per diluted share (EPS) in fiscal year 2025. This represents an increase of 103.1% from the prior year.
Not reported for fiscal year 2025.
Cash & Balance Sheet
Invesco Mort held $56.0M in cash as of fiscal year 2025; long-term debt is not reported for that period.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Margins & Returns
Invesco Mort's net profit margin was 34.3% in fiscal year 2025, showing the share of revenue converted to profit. This is up 13.4 percentage points from the prior year.
Invesco Mort's ROE was 12.7% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is up 4.5 percentage points from the prior year.
Not reported for fiscal year 2025.
Not reported for fiscal year 2025.
Capital Allocation
None of these metrics is reported for fiscal year 2025.
IVR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $315.9M | $295.3M+3.1% | $286.5M+3.1% | $277.9M+42.9% | $194.5M+15.0% | $169.2M-39.6% | $280.2M-64.0% | $778.4M+21.0% | $643.0M+18.0% | $545.1M | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A Expenses | $7.6M | $7.3M+1.6% | $7.2M-3.9% | $7.4M-11.6% | $8.4M+3.3% | $8.2M-24.9% | $10.9M+35.8% | $8.0M+13.2% | $7.1M-1.7% | $7.2M-1.0% | $7.3M-6.5% | $7.8M-15.5% | $9.2M+9.8% | $8.4M+107.8% | $4.0M+4.3% | $3.9M |
| Interest Expense | $219.8M | $219.9M-12.0% | $249.7M+9.4% | $228.2M+342.6% | $51.6M+556.7% | -$11.3M-113.7% | $82.3M-82.6% | $472.3M+39.4% | $338.9M+72.4% | $196.6M+24.9% | $157.4M-43.4% | $278.0M-1.4% | $281.9M-15.2% | $332.3M+40.0% | $237.4M+52.9% | $155.2M |
| Net Income | $120.1M | $101.3M+69.1% | $59.9M+477.6% | -$15.9M+96.1% | -$402.9M-347.7% | -$90.0M+94.6% | -$1.7B-559.9% | $364.1M+614.3% | -$70.8M-120.3% | $348.6M+37.0% | $254.4M+125.7% | $112.7M+152.4% | -$215.1M-236.0% | $158.2M-53.3% | $338.7M+20.1% | $281.9M |
| EPS (Diluted) | — | $1.32+103.1% | $0.65 | -$0.85 | -$12.21 | -$4.82 | -$98.93 | $2.42 | -$1.03 | $2.75+38.9% | $1.98+167.6% | $0.74+139.2% | -$1.89-270.3% | $1.11-61.5% | $2.88-11.9% | $3.27 |
Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, Income Tax.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IVR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $6.5B+13.9% | $5.7B+7.6% | $5.3B+3.7% | $5.1B-39.6% | $8.4B-2.2% | $8.6B-61.4% | $22.3B+25.4% | $17.8B-4.5% | $18.7B+18.8% | $15.7B-6.3% | $16.8B-21.0% | $21.2B+4.3% | $20.4B+7.6% | $18.9B+28.0% | $14.8B |
| Cash & Equivalents | $56.0M-23.7% | $73.4M-4.6% | $77.0M-56.2% | $175.5M-50.8% | $357.1M+141.3% | $148.0M-14.2% | $172.5M+27.2% | $135.6M+53.4% | $88.4M-45.4% | $161.8M+204.1% | $53.2M-67.6% | $164.1M-22.1% | $210.6M-26.5% | $286.5M+45.3% | $197.2M |
| Total Liabilities | $5.7B+14.5% | $5.0B+10.1% | $4.5B+4.8% | $4.3B-39.0% | $7.0B-3.1% | $7.3B-62.6% | $19.4B+25.0% | $15.5B-3.0% | $16.0B+19.1% | $13.4B-7.3% | $14.5B-22.0% | $18.6B+3.6% | $17.9B+9.9% | $16.3B+27.0% | $12.9B |
| Long-Term Debt | N/A | N/A | N/A | N/A | N/A | N/A | $19.2B+25.8% | $15.3B-3.9% | $15.9B+20.2% | $13.2B | N/A | N/A | N/A | N/A | N/A |
| Total Equity | $797.5M+9.1% | $730.7M-6.6% | $782.7M-2.7% | $804.1M-42.7% | $1.4B+2.6% | $1.4B-53.4% | $2.9B+28.2% | $2.3B-13.1% | $2.6B+17.4% | $2.2B0.0% | $2.2B-14.1% | $2.6B+9.9% | $2.4B-7.1% | $2.6B+35.2% | $1.9B |
| Retained Earnings | -$3.6B-0.2% | -$3.6B-1.5% | -$3.5B-3.3% | -$3.4B-18.2% | -$2.9B-9.0% | -$2.6B-224.7% | -$814.5M+7.7% | -$882.1M-52.3% | -$579.3M+19.3% | -$718.3M+6.9% | -$771.3M-21.9% | -$632.9M-329.6% | -$147.3M-881.7% | $18.8M+225.1% | -$15.1M |
Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Goodwill, Current Liabilities.
IVR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.
| Metric | TTM | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $166.0M | $157.1M-14.2% | $183.2M-23.0% | $237.8M+21.3% | $196.1M+28.8% | $152.3M-10.7% | $170.5M-50.4% | $343.4M+12.8% | $304.3M+4.7% | $290.6M-1.8% | $295.8M-17.5% | $358.6M-5.6% | $379.7M-22.6% | $490.4M+14.7% | $427.4M+40.0% | $305.4M |
| Investing Cash Flow | -$1.8B | -$892.9M-79.5% | -$497.4M+7.3% | -$536.8M-122.1% | $2.4B+1907.5% | $120.7M-99.0% | $11.6B+367.2% | -$4.3B-795.7% | $621.6M+120.1% | -$3.1B-415.2% | $979.7M-20.8% | $1.2B+235.7% | -$912.4M+60.4% | -$2.3B+37.4% | -$3.7B+59.8% | -$9.1B |
| Financing Cash Flow | $1.7B | $691.3M+111.7% | $326.5M+49.2% | $218.9M+107.5% | -$2.9B-3195.0% | -$88.6M+99.2% | -$11.6B-381.1% | $4.1B+570.3% | -$879.2M-132.3% | $2.7B+333.5% | -$1.2B+31.6% | -$1.7B-451.1% | $486.3M-72.0% | $1.7B-48.0% | $3.3B-62.8% | $9.0B |
| Dividends Paid | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -$5.4M-102.0% | $267.5M |
| Share Buybacks | N/A | N/A | N/A | N/A | N/A | N/A | $0 | $0-100.0% | $1.1M | $0-100.0% | $25.0M-80.1% | $125.6M+494.4% | $21.1M-86.8% | $160.5M | $0 | N/A |
Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings. A row marked — cannot be summed at all, because a quarter in the window reports no per-share figure; a row marked N/A could be summed, but a quarter in the window does not report that metric.
IVR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples.
| Metric | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Margin | 34.3%+13.4pp | 20.9%+26.6pp | -5.7% | -207.1% | -53.2% | -597.6% | 46.8%+57.8pp | -11.0%-75.0pp | 64.0% | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity | 12.7%+4.5pp | 8.2%+10.2pp | -2.0%+48.1pp | -50.1%-43.7pp | -6.4%+116.0pp | -122.5%-134.9pp | 12.4%+15.5pp | -3.1%-16.4pp | 13.3%+1.9pp | 11.3%+6.3pp | 5.0%+13.3pp | -8.2%-14.9pp | 6.7%-6.6pp | 13.2%-1.7pp | 14.9% |
| Return on Assets | 1.6%+0.5pp | 1.1%+1.4pp | -0.3%+7.6pp | -7.9%-6.8pp | -1.1%+18.3pp | -19.4%-21.0pp | 1.6%+2.0pp | -0.4%-2.3pp | 1.9%+0.3pp | 1.6%+0.9pp | 0.7%+1.7pp | -1.0%-1.8pp | 0.8%-1.0pp | 1.8%-0.1pp | 1.9% |
| Debt-to-Equity | 7.12+0.3x | 6.78+1.0x | 5.75+0.4x | 5.34+0.3x | 5.02-0.3x | 5.31-1.2x | 6.54-0.1x | 6.67+0.6x | 6.03+0.1x | 5.89-0.6x | 6.47-0.7x | 7.12-0.4x | 7.55+1.2x | 6.38-0.4x | 6.79 |
Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio, FCF Margin.
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Net Margin.
Similar Companies
Where Invesco Mort Ranks
Frequently Asked Questions
What is Invesco Mort's annual revenue?
Invesco Mort (IVR) reported $295.3M in total revenue for fiscal year 2025. This represents a 3.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Invesco Mort's revenue growing?
Invesco Mort (IVR) revenue grew by 3.1% year-over-year, from $286.5M to $295.3M in fiscal year 2025.
Is Invesco Mort profitable?
Yes, Invesco Mort (IVR) reported a net income of $101.3M in fiscal year 2025, with a net profit margin of 34.3%.
What is Invesco Mort's net profit margin?
Invesco Mort (IVR) had a net profit margin of 34.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Invesco Mort's return on equity (ROE)?
Invesco Mort (IVR) has a return on equity of 12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Invesco Mort's operating cash flow?
Invesco Mort (IVR) generated $157.1M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Invesco Mort's total assets?
Invesco Mort (IVR) had $6.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What is Invesco Mort's debt-to-equity ratio?
Invesco Mort (IVR) had a debt-to-equity ratio of 7.12 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.
What is Invesco Mort's return on assets (ROA)?
Invesco Mort (IVR) had a return on assets of 1.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Invesco Mort's Piotroski F-Score?
Invesco Mort (IVR) has a Piotroski F-Score of 4 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Invesco Mort's earnings high quality?
Invesco Mort (IVR) has an earnings quality ratio of 1.55x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.